To test the effects of GRK3 on tumor growth and metastasis in vivo, we used GRK3-deficient mammary tumor cells derived from Balb/c (66cl4-luc) as a representative TNBC model system in an immunocompetent mouse [21]. Here, GRK3 is linked to breast cancer.